Estrogen Replacement Therapy and Cognitive Function in Older Women

JAMA: The Journal of the American Medical Association

Volumn 269, Issue 20, 1993, Pages 2637-2641

  Barrett Connor, Elizabeth ^a   Kritz Silverstein, Donna ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN;

AGED; AMNESIA; ARTICLE; COGNITION; DEMENTIA; EDUCATION; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; STATISTICAL ANALYSIS; SURVIVAL;

AGED; AGED, 80 AND OVER; CALIFORNIA; COGNITION; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMAN; PROSPECTIVE STUDIES; PSYCHOLOGICAL TESTS;

EID: 0027280303     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1993.03500200051032     Document Type: Article

References (39)

1. Ernster VL, Bush TL, Huggins GR, Hulka BS, Kelsey JL, Schottenfeld D. Benefits and risks of menopausal estrogen and/or progestin hormone use. Prev Med. 1988;17:201-222.
2. Barrett-Connor E. Risks and benefits of replacement estrogen. In: Creger WP, Coggins CH, Hancock EW, eds. Annual Review of Medicine. Palo Alto, Calif: Annual Reviews Inc; 1992;43:239-251.
3. Grady D, Rubin SM, Petitti D, et al. Hormone therapy to prevent disease and prolong life in post-menopausal women. Ann Intern Med. 1992;117:1016-1037.
4. Malleson J. An endocrine factor in certain affective disorders. Lancet. 1953;2:158-164.
5. Kopera H. Estrogens and psychic functions. Front Horm Res. 1973;2:118-133.
6. Anderson E, Hamburger S, Liu JH, Rebar RW. Characteristics of menopausal women seeking assistance. Am J Obstet Gynecol. 1987;156:428-433.
7. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol. 1977;4:31-47.
8. Hackman BW, Gallbraith D. Six-month study of oestrogen therapy with piperazine oestrone sulphate and its effects on memory. Curr Med Res Opin. 1977;4:21-27.
9. Fedor-Freybergh P. The influence of oestrogen on the well-being and mental performance in climacteric and postmenopausal women. Acta Obstet Gynaecol Scand. 1977;64:5-69.
10. Rauramo L, Langerspetz K, Engblom P, Punnonen R. The effect of castration and peroral estrogen therapy on some psychological functions. Front Horm Res. 1975;8:133-151.
11. Vanhulle G, Demol R. A double-blind study into the influence of estriol on a number of psychological tests in post-menopausal women. In: van Keep PA, Greenblatt RB, Albeaux-Fernet M, eds. Consensus on Menopausal Research. Lancaster, England: MTP Press Ltd; 1976:94-99.
12. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology. 1988;13:345-357.
13. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol. 1991;78:991-995.
14. Luine VN, Khylchevskaya RI, McEwen B. Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res. 1975;86:293-306.
15. Luine VN, Park D, Joh T, Reis D, McEwen B. Immuno-chemical demonstration of increased choline acetyltransferase concentration in rat preoptic area after estradiol administration. Brain Res. 1980; 191:273-277.
16. Whitehouse PJ, Price DL, Clark AW, Struble RG, Coyle JT. Alzheimer’s disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol. 1981;10:122-126.
17. Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of memory dysfunction. Science. 1982;17:408-417.
18. Wong M, Moss RL. Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA 1 neurons. J Neurosci. 1992;12:3217-3225.
19. McEwen BS. Steroid hormones are multifunctional messengers to the brain. Trends Endocrinol Metab. 1991;2:62-67.
20. Gangar KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet. 1991;338:839-842.
21. Meade TW, Berra A. Hormone replacement therapy and cardiovascular disease. Br Med Bull. 1992;48:276-308.
22. Aylward M. Plasma tryptophan levels and mental depression in postmenopausal subjects: effects of oral piperazine-oestrone sulphate. Int Res Commun Syst Med Sci. 1973;1:30-34.
23. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y. Estrogen replacement therapy for severe persistent depressions in women. Arch Gen Psychiatry. 1979;36:550-554.
24. Raskin A, Friedman AS, DiMascio A. Cognitive and performance deficits in depression. Psychopharm Bull. 1982;18:196-202.
25. Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology. 1974;24:1019-1025.
26. Russell EW. A multiple scoring method for the assessment of complex memory functions. J Consult Clin Psychol. 1975;43:800-809.
27. Wechsler D. A standardized memory scale for clinical use. J Psychol. 1945:19:87-95.
28. Folstein MF, Folstein SE, McHugh PR. ‘Mini-Mental State’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
29. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile changes in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114:797-811.
30. Reitan R. Validity of the trail-making test as an indicator of organic brain disease. Percept Mot Skills. 1958;8:271-276.
31. Borkowski JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologia. 1967; 5:135-140.
32. Kittner SJ, White LR, Farmer ME, et al. Methodological issues in screening for dementia: the problem of education adjustment. J Chronic Dis. 1986; 39:163-170.
33. Fillit H, Weinreb H, Cholst I, et al. Observations in a preliminary open trial of estradiol therapy for senile dementia—Alzheimer’s type. Psychoneuroendocrinology. 1986;11:337-345.
34. Weiss BL. Failure of nalmefene and estrogen to improve memory in Alzheimer’s disease. Am J Psychiatry. 1987;144:386-387.
35. Honjo H, Ogino Y, Naitoh K, et al. In vivo effects by estrone sulfate on the central nervous system—senile dementia (Alzheimer’s type). J Steroid Biochem Mol Biol. 1989;34:511-515.
36. Palinkas LA, Barrett-Connor E. Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol. 1992;80:30-36.
37. Liu IY, LaCroix AZ, White LR, Kittner SJ, Wolf PA. Cognitive impairment and mortality: a study of possible confounders. Am J Epidemiol. 1990;132:136-143.
38. Evans DA, Smith LA, Scherr PA, Albert MS, Funkenstein HH, Hebert LE. Risk of death from Alzheimer’s disease in a community population of older persons. Am J Epidemiol. 1991;134:403-412.
39. Bush TL, Cowan LD, Barrett-Connor E, et al. Estrogen use and all cause mortality: preliminary results from the Lipid Research Clinics Program Follow-up Study. JAMA. 1983;249:903-906.